Rafferty Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,995
| Closed | -$84K | – | 1140 |
|
|
2022
Q2 | $84K | Buy |
6,995
+2,507
| +56% | +$30.1K | ﹤0.01% | 1076 |
|
|
2022
Q1 | $59K | Sell |
4,488
-423
| -9% | -$5.56K | ﹤0.01% | 1201 |
|
|
2021
Q4 | $86K | Buy |
4,911
+1,591
| +48% | +$27.9K | ﹤0.01% | 1265 |
|
|
2021
Q3 | $72K | Sell |
3,320
-41,459
| -93% | -$899K | ﹤0.01% | 1247 |
|
|
2021
Q2 | $1.57M | Sell |
44,779
-12,922
| -22% | -$452K | 0.01% | 748 |
|
|
2021
Q1 | $5.69M | Buy |
57,701
+49,118
| +572% | +$4.84M | 0.04% | 258 |
|
|
2020
Q4 | $930K | Sell |
8,583
-7,452
| -46% | -$807K | 0.01% | 524 |
|
|
2020
Q3 | $1.65M | Buy |
16,035
+12,573
| +363% | +$1.3M | 0.02% | 473 |
|
|
2020
Q2 | $723K | Buy |
3,462
+2,199
| +174% | +$459K | 0.01% | 620 |
|
|
2020
Q1 | $123K | Sell |
1,263
-9,466
| -88% | -$922K | 0.01% | 551 |
|
|
2019
Q4 | $1.24M | Sell |
10,729
-26,841
| -71% | -$3.09M | 0.02% | 497 |
|
|
2019
Q3 | $2.05M | Buy |
37,570
+33,312
| +782% | +$1.82M | 0.03% | 375 |
|
|
2019
Q2 | $506K | Buy |
+4,258
| New | +$506K | 0.01% | 688 |
|